Use of mycophenolate mofetil for tacrolimus related chronic nephrotoxicity in liver transplant recipients

被引：0
|
作者：
Jain, A [1 ]
Fung, J [1 ]
Hamad, I [1 ]
Zuckerman, S [1 ]
Starzl, TE [1 ]
Venkataramanan, DR [1 ]
机构：
[1] UNIV PITTSBURGH,MED CTR,SCH PHARM,THOMAS E STARZL TRANSPLANTAT INST,PITTSBURGH,PA
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：427 / 427
页数：1
相关论文
共 50 条
  • [31] A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients - An interim report
    Jain, AB
    Hamad, I
    Rakela, J
    Dodson, F
    Kramer, D
    Demetris, J
    McMichael, J
    Starzl, TE
    Fung, JJ
    TRANSPLANTATION, 1998, 66 (10) : 1395 - 1398
  • [32] Use of Mycophenolate Mofetil in Liver Transplant Patients.
    Bravo, Gomez M. A.
    Barrera, L.
    Jimenez, M.
    Rodrigo, J.
    Marin, D.
    De la Mata, M.
    Garcia, Nunez F.
    Garrido, Lopez M. A.
    Noguera, F.
    Vivaldi, Martin R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 532
  • [33] Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Roth, D
    Kupin, W
    Rosen, A
    Gomez, C
    Mattiazzi, A
    Esquenazi, V
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1617 - 1618
  • [34] Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients:: Preliminary report in Chile
    Mueller, H.
    Solari, S.
    Zuniga, C.
    Pedreros, C.
    Troncoso, J.
    Morente, C.
    Ovalle, R.
    Acosta, P.
    Chavez, T.
    Albornoz, E.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) : 705 - 707
  • [35] Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients
    Teebken, OE
    Strüber, M
    Harringer, W
    Pichlmaier, MA
    Haverich, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (04) : 1265 - 1268
  • [36] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [37] Tacrolimus or cyclosporine:: Which is the better partner for mycophenolate-mofetil in heart transplant recipients?
    Meiser, BM
    Groetzner, J
    Kaczmarek, I
    Landwehr, P
    Müller, M
    Jung, S
    Überfuhr, P
    Fraunberger, P
    Stempfle, HU
    Weis, M
    Reichart, B
    TRANSPLANTATION, 2004, 78 (04) : 591 - 598
  • [38] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
  • [39] Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen
    Greanya, Erica D.
    Poulin, Eric
    Partovi, Nilufar
    Shapiro, R. Jean
    Al-Khatib, Mai
    Ensom, Mary H. H.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (02) : 134 - 142
  • [40] BUDGET IMPACT OF THE TACROLIMUS-MYCOPHENOLATE MOFETIL REGIMEN ON HEART TRANSPLANT RECIPIENTS IN COLOMBIA
    Lasalvia, P.
    Hernandez, F.
    Montoya, G.
    VALUE IN HEALTH, 2021, 24 : S71 - S71
12345